← Back to headlines
Halozyme Projects Over $1B in ENHANZE Royalties by 2026, Announces $1B Share Buyback
Halozyme Therapeutics has outlined projections for its ENHANZE royalties to exceed $1 billion by 2026 and announced a new $1 billion share buyback program.
12 May, 02:53 — 12 May, 02:53
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
44m ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
1h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
4h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
10h ago